SCHEMBL20194173

SCHEMBL20194173

CCC(C)(C)C(=O)NC(=N)c1cccc(N/C(=N/C=N)c2[nH]ccc2CN2CCC(N)CC2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 1/20 0.36
▸ F10 P00742 1/20 0.34
▸ HPN P05981 1/20 0.34
▸ PRSS1 P07477 1/20 0.34
▸ PRSS2 P07478 1/20 0.34
▸ PRSS3 P35030 1/20 0.34
▸ HGFAC Q04756 1/20 0.34
▸ ST14 Q9Y5Y6 1/20 0.34
▸ CCR3 P51677 6/20 0.33
▸ AAK1 Q2M2I8 2/20 0.33
▸ EGFR P00533 1/20 0.33
▸ BRAF P15056 1/20 0.33
▸ ACKR3 P25106 4/20 0.32
▸ SMYD3 Q9H7B4 1/20 0.32
▸ MAP3K20 Q9NYL2 1/20 0.32
▸ MAP3K7 O43318 1/20 0.31
▸ MAP4K2 Q12851 1/20 0.31
▸ MAPK14 Q16539 1/20 0.31
▸ NPY2R P49146 1/20 0.31
▸ UBE2M P61081 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20194180 0.94 F10 (0.35) F10HPNPRSS1PRSS2PRSS3
SCHEMBL20194195 0.88 F10 (0.36) F10HPNPRSS1PRSS2PRSS3
SCHEMBL20194230 0.85 ACKR3 (0.38) ACKR3
SCHEMBL20194193 0.85 F10 (0.36) F10HPNPRSS1PRSS2PRSS3
SCHEMBL20194179 0.84 F10 (0.44) F10HPNPRSS1PRSS2PRSS3
SCHEMBL20194187 0.82 CCR3 (0.34) F10HPNPRSS1PRSS2PRSS3
SCHEMBL20194170 0.82 F10 (0.37) F10HPNPRSS1PRSS2PRSS3
SCHEMBL20194226 0.81 AAK1 (0.33) F10HPNPRSS1PRSS2PRSS3
SCHEMBL20194167 0.80 F10 (0.37) F10HPNPRSS1PRSS2PRSS3
SCHEMBL20194162 0.80 F10 (0.34) F10HPNPRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3054955-B1 PYRROLOTRIAZINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-05-30 — — EP disclosed
Send feedback